Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The Zepbound (tirzepatide) pens have a list price of around $1,000 without insurance
Boehringer Ingelheims survodutide (glucagon/GLP-1), the first new competitor to enter the market outside the dominant Novo Nordisk/Lilly duopoly
The benefits vary by patient but may include: Significant weight loss: These medications have been shown to promote substantial weight loss in clinical trials
In fact, a 2024 KFF Health Tracking survey found that 1 in 8 adults have used Ozempic or a similar medication
doi: 10.5144/0256-4947.2012.455 22 FaggianoAPivonelloRSpieziaSDe MartinoMCFilippellaMDi SommaCet al
US$ 25.10
US$ 21.10
US$ 28.86
US$ 26.35
US$ 21.94
